Piramal Pharma Solutions Press Releases

Press Releases

Piramal Healthcare Invests £2.0 mn in Scotland

Posted on Thu, Feb 11, 2016 @ 08:47 AM by Piramal Pharma Solutions in antibody drug conjugates

17th November 2015: Piramal Healthcare UK Ltd., has invested £2.0 million into Scotland to expand its manufacturing base at Grangemouth, to manufacture Antibody Drug Conjugates to global markets. This new investment into Scotland will yield additional revenue of £3-5 mn over 5 years to Piramal Healthcare’s revenues.

0 CommentsContinue Reading →

Coldstream to Attend Bio International Convention 2015

Posted on Fri, Jun 12, 2015 @ 05:04 PM by Jason Dwinell in lyophilized products, in aseptic filling, in antibody drug conjugates

Coldstream Laboratories, Inc., a Piramal Enterprises business, will be attending Bio Internatinal Convention 2015 in Philadelphia, PA. The event will take place at the Pennsylvania Convention Center June 15-18, 2015.

0 CommentsContinue Reading →

Piramal Enterprises acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

Posted on Fri, Jan 23, 2015 @ 05:10 PM by Kathy Sue Bennett in lyophilization, in parenteral manufacturing, in parenteral development, in sterile manufacturing, in antibody drug conjugates

Mumbai, 16th January, 2015: Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announced that it has invested USD 30.65 million towards acquiring Coldstream Laboratories Inc. (‘Coldstream’), through its wholly owned subsidiary in the USA in an all cash transaction.  Of this, USD 5.65 million would be towards the purchase of the facility building which is currently leased to Coldstream, while the rest would be towards purchase of 100% of the company’s shares. Coldstream is a Contract Development and Manufacturing Organisation (CDMO) focused on the development and manufacturing of sterile injectable products.

0 CommentsContinue Reading →

Coldstream to Exhibit at World ADC Conference

Posted on Thu, Oct 10, 2013 @ 09:40 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling, in antibody drug conjugates

Coldstream and Goodwin Biotechnology will co-exhibit at the World ADC Summit in San Francisco, CA, from October 14th to 17th.  Please meet us at Booth #13 to discuss your cytotoxic antibody drug conjugation needs.

0 CommentsContinue Reading →

Goodwin Biotechnology and Coldstream Laboratories Announce a Collaboration to Develop and Manufacture Cytotoxic Antibody Drug Conjugates

Posted on Tue, Apr 30, 2013 @ 09:53 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling, in antibody drug conjugates

Plantation, Florida and Lexington, Kentucky-- Goodwin Biotechnology, Inc. (GBI) and Coldstream Laboratories, Inc. have established a collaboration for developing and manufacturing high-potency, highly cytotoxic materials (e.g., small molecules, protein toxins, cytotoxic antibody drug conjugates, and other bioconjugates).

0 CommentsContinue Reading →